C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in October 2015 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
110
Frequently Asked Questions
What is Market Cap of C4 Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. C4 Therapeutics Inc market cap is $187.89M.
What is the 52-week high for C4 Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. C4 Therapeutics Inc 52 week high is $7.22 as of September 11, 2025.
What is the 52-week low for C4 Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. C4 Therapeutics Inc 52 week low is $1.09 as of September 11, 2025.
What is C4 Therapeutics Inc stock price today?
C4 Therapeutics Inc stock price today is $2.73.
What was C4 Therapeutics Inc stock price yesterday?
C4 Therapeutics Inc stock price yesterday was $2.64.
What is the PE ratio of C4 Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. C4 Therapeutics Inc’s P/E ratio is -1.67.
What is the Price-to-Book ratio of C4 Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. C4 Therapeutics Inc P/B ratio is 1.0770.
What is the 50-day moving average of C4 Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. C4 Therapeutics Inc 50-day moving average is $2.30.
